Indication

GLP-1 medications for Obstructive sleep apnea with obesity

GLP-1 medications for Obstructive sleep apnea with obesity, with sourced prices, shortage reports and study results.

Last checked · Nov 16, 2026 UTC
1approved

Approved for this use

Alphabetical by active ingredient. Approved uses depend on the specific brand and formulation.

Tirzepatide

Mounjaro, Zepbound

FDA-approved for

  • Weight loss
  • Type 2 diabetes
  • Heart risk
  • Sleep apnea

Subcutaneous injection · Once weekly

FDA shortage report (accessdata.fda.gov/scripts/drugshortages)

Published entry quote

$299/28 days (pharmacy.amazon.com/ZEPBOUND-KWIKPEN-2-5-MG-DOSE-PEN-INJ/dp/B0GP27N9T3)

Zepbound KwikPen via Amazon Pharmacy · Amazon Pharmacy

Checked on pharmacy.amazon.com

Price conditions

without insurance, 2.5 mg; includes the manufacturer coupon if eligible (list price $498.98); prescription required

The 7.5 mg KwikPen is also $449. Amazon fills a prescription you already have and delivers in all 50 states. FDA-approved product.

28-day supply

Checked . Entry quotes are not estimates of ongoing treatment cost.

Prices, evidence & safety
Word for word

What each FDA label says about obstructive sleep apnea with obesity

From the indications section of each manufacturer's current label. A brand's wording decides who it is approved for.

  • Zepbound: “to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity.”FDA label, revised Aug 28, 2026 (dailymed.nlm.nih.gov/dailymed/drugInfo.cfm)
From FDA and CMS records

Timing, generics and coverage

Read from each FDA label, FDA's Orange Book and CMS's Part D files, and updated when they change.

BrandSoonest top doseHalf-lifeGeneric approved?Patent on the medicine toOn Medicare Part D, 2025
Mounjaro15 mg from week 21about 5 daysNoJun 14, 20391,592,517
Zepbound15 mg from week 21about 5-6 daysNoMay 13, 2036160,298

How long each takes · Generics and patents · Who covers what

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.